CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 4/A Open-market sale VP, Controller and PAO sold 254 shares at $65.52 ($16,642)
- 4/A Open-market sale EVP & Chief Tech Ops Officer sold 626 shares at $65.52 ($41,016)
- 4/A Open-market sale Pinion John Richard sold 722 shares at $65.52 ($47,305)
- 4/A Open-market sale EVP and General Counsel sold 886 shares at $65.52 ($58,051)
- 4/A Open-market sale CFO & Executive Vice President sold 14,800 shares at $70.00 ($1,036,000)
- 4/A Open-market sale CFO & Executive Vice President sold 1,012 shares at $65.52 ($66,306)
- 4/A Open-market sale President & CEO sold 2,890 shares at $65.52 ($189,353)
- 4 Open-market sale CFO & Executive Vice President sold 14,800 shares at $70.00 ($1,036,000)
- 4 Shares withheld for taxes VP, Controller and PAO gave up 246 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Tech Ops Officer gave up 607 shares (to pay taxes)
- 4 Shares withheld for taxes Pinion John Richard gave up 701 shares (to pay taxes)
- 4 Grant or award EVP and Chief Medical Officer acquired 7,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 5,000 shares (grant or award)
- 4 Shares withheld for taxes CBO & EVP gave up 806 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and General Counsel gave up 860 shares (to pay taxes)
- 4 Shares withheld for taxes CFO & Executive Vice President gave up 981 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 2,802 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and Chief Medical Officer gave up 1,636 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 19 of 32 · 627 filings